Commercial Services Healthcare Sector

Healius

Market Cap: AU$708.0m

Provides specialty diagnostic services to consumer and practitioners in Australia.

Clarity Pharmaceuticals

Market Cap: AU$707.0m

A clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States.

kneat.com

Market Cap: CA$621.4m

Designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific.

PYC Therapeutics

Market Cap: AU$699.9m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Sana Biotechnology

Market Cap: US$451.1m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

Maze Therapeutics

Market Cap: US$450.2m

A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.

Botanix Pharmaceuticals

Market Cap: AU$696.1m

Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.

Tilray Brands

Market Cap: US$446.8m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

Cross Country Healthcare

Market Cap: US$443.2m

Provides talent management services for healthcare clients in the United States.

Sonida Senior Living

Market Cap: US$441.0m

Owns and operates senior housing communities in the United States.

Orthofix Medical

Market Cap: US$440.0m

Operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally.

PureTech Health

Market Cap: UK£324.3m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Bioventus

Market Cap: US$432.0m

A medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally.

Senseonics Holdings

Market Cap: US$424.7m

A commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.

CytoDyn

Market Cap: US$423.9m

A clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications.

Vitalhub

Market Cap: CA$581.3m

Provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally.

ORIC Pharmaceuticals

Market Cap: US$423.0m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.

Septerna

Market Cap: US$422.4m

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

Development Technologies

Market Cap: US$420.0m

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies.

Oruka Therapeutics

Market Cap: US$419.0m

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

Knight Therapeutics

Market Cap: CA$573.9m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

SIGA Technologies

Market Cap: US$417.2m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Paragon Care

Market Cap: AU$645.6m

Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia.

Surmodics

Market Cap: US$417.0m

Provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally.

Tectonic Therapeutic

Market Cap: US$414.5m

A biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs).

Sage Therapeutics

Market Cap: US$413.9m

A biopharmaceutical company, develops and commercializes brain health medicines.

Northwest Biotherapeutics

Market Cap: US$411.6m

A biotechnology company, focuses on developing personalized immune therapies for cancer.

Verastem

Market Cap: US$411.0m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Precigen

Market Cap: US$410.3m

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Personalis

Market Cap: US$408.1m

Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

Autolus Therapeutics

Market Cap: US$407.2m

A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.

Celcuity

Market Cap: US$407.1m

A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.

MeiraGTx Holdings

Market Cap: US$406.6m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

MBX Biosciences

Market Cap: US$406.1m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

Zhengye Biotechnology Holding

Market Cap: US$404.2m

Engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.

Atai Life Sciences

Market Cap: US$403.6m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.